Popular Filters
Trials for Sacral Dysgenesis Patients
Hormone Therapy
Micronized Progesterone for Turner Syndrome
Recruiting3 awardsPhase 4
Kansas City, Missouri
This trial is comparing the effects of giving progesterone supplements either continuously or in a sequence to Turner Syndrome patients with primary ovarian insufficiency who are taking hormone replacement therapy.
C-type natriuretic peptide analog
Vosoritide for Turner Syndrome
Recruiting1 awardPhase 2
Washington, District of Columbia
This trial tests vosoritide, a medication that helps bone growth, in young girls with Turner syndrome who are short. It aims to see if vosoritide can help them grow taller, especially if they haven't responded well to other treatments.
Growth Hormone Medicine
Somapacitan for Growth Hormone Deficiency in Children
Recruiting2 awardsPhase 3
Sacramento, California
This trial is testing somapacitan, a new growth hormone medicine, in children who have low levels of growth hormone. These children include those born small for their age or with conditions like Turner syndrome, Noonan syndrome, or idiopathic short stature. Somapacitan is given as an injection to help them grow better. Somapacitan is a long-acting growth hormone derivative developed for periodic administration, already approved for use in adult GH deficiency in the USA and Japan.
Growth Hormone
Lonapegsomatropin vs Somatropin for Turner Syndrome
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing a new growth hormone treatment for young children with Turner syndrome to help them grow. The new treatment lasts longer in the body, so it doesn't need to be given as frequently. Growth hormone therapy has been used for many years to treat Turner syndrome, showing varied results in improving height.
Behavioural Intervention
PIXI for Neurogenetic Disorders
Recruiting1 award2 criteria
Research Triangle Park, North Carolina
This trial tests a program called PIXI, which helps parents of infants with genetic disorders. The program educates parents about their baby's condition, coaches them on how to interact with their baby, and provides family support. The goal is to improve the baby's development and family well-being.
Trials for TS Patients
Hormone Therapy
Micronized Progesterone for Turner Syndrome
Recruiting3 awardsPhase 4
Kansas City, Missouri
This trial is comparing the effects of giving progesterone supplements either continuously or in a sequence to Turner Syndrome patients with primary ovarian insufficiency who are taking hormone replacement therapy.
C-type natriuretic peptide analog
Vosoritide for Turner Syndrome
Recruiting1 awardPhase 2
Washington, District of Columbia
This trial tests vosoritide, a medication that helps bone growth, in young girls with Turner syndrome who are short. It aims to see if vosoritide can help them grow taller, especially if they haven't responded well to other treatments.
Growth Hormone Medicine
Somapacitan for Growth Hormone Deficiency in Children
Recruiting2 awardsPhase 3
Sacramento, California
This trial is testing somapacitan, a new growth hormone medicine, in children who have low levels of growth hormone. These children include those born small for their age or with conditions like Turner syndrome, Noonan syndrome, or idiopathic short stature. Somapacitan is given as an injection to help them grow better. Somapacitan is a long-acting growth hormone derivative developed for periodic administration, already approved for use in adult GH deficiency in the USA and Japan.
Growth Hormone
Lonapegsomatropin vs Somatropin for Turner Syndrome
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing a new growth hormone treatment for young children with Turner syndrome to help them grow. The new treatment lasts longer in the body, so it doesn't need to be given as frequently. Growth hormone therapy has been used for many years to treat Turner syndrome, showing varied results in improving height.
Behavioural Intervention
PIXI for Neurogenetic Disorders
Recruiting1 award2 criteria
Research Triangle Park, North Carolina
This trial tests a program called PIXI, which helps parents of infants with genetic disorders. The program educates parents about their baby's condition, coaches them on how to interact with their baby, and provides family support. The goal is to improve the baby's development and family well-being.
Trials With No Placebo
Hormone Therapy
Micronized Progesterone for Turner Syndrome
Recruiting3 awardsPhase 4
Kansas City, Missouri
This trial is comparing the effects of giving progesterone supplements either continuously or in a sequence to Turner Syndrome patients with primary ovarian insufficiency who are taking hormone replacement therapy.
Procedure
Gonadal Tissue Cryopreservation for Fertility Preservation
Recruiting1 award3 criteria
Aurora, Colorado
This trial aims to investigate a method called gonadal tissue cryopreservation for preserving fertility in patients with certain disorders. These disorders can increase the risk of cancer and infertility. The study will assess how safe
C-type natriuretic peptide analog
Vosoritide for Turner Syndrome
Recruiting1 awardPhase 2
Washington, District of Columbia
This trial tests vosoritide, a medication that helps bone growth, in young girls with Turner syndrome who are short. It aims to see if vosoritide can help them grow taller, especially if they haven't responded well to other treatments.
Growth Hormone Medicine
Somapacitan for Growth Hormone Deficiency in Children
Recruiting2 awardsPhase 3
Sacramento, California
This trial is testing somapacitan, a new growth hormone medicine, in children who have low levels of growth hormone. These children include those born small for their age or with conditions like Turner syndrome, Noonan syndrome, or idiopathic short stature. Somapacitan is given as an injection to help them grow better. Somapacitan is a long-acting growth hormone derivative developed for periodic administration, already approved for use in adult GH deficiency in the USA and Japan.
Growth Hormone
Lonapegsomatropin vs Somatropin for Turner Syndrome
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing a new growth hormone treatment for young children with Turner syndrome to help them grow. The new treatment lasts longer in the body, so it doesn't need to be given as frequently. Growth hormone therapy has been used for many years to treat Turner syndrome, showing varied results in improving height.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.